Literature DB >> 24626533

Pertussis pathogenesis--what we know and what we don't know.

Erik L Hewlett1, Drusilla L Burns, Peggy A Cotter, Eric T Harvill, Tod J Merkel, Conrad P Quinn, E Scott Stibitz.   

Abstract

Pertussis is a worldwide public health threat. Bordetella pertussis produces multiple virulence factors that have been studied individually, and many have recently been found to have additional biological activities. Nevertheless, how they interact to cause the disease pertussis remains unknown. New animal models, particularly the infection of infant baboons with B. pertussis, are enabling longstanding questions about pertussis pathogenesis to be answered and new ones to be asked. Enhancing our understanding of pathogenesis will enable new approaches to the prevention and control of pertussis.

Entities:  

Keywords:  Bordetella pertussis; pathogenesis; pertussis; virulence factors; whooping cough

Mesh:

Substances:

Year:  2014        PMID: 24626533      PMCID: PMC3952676          DOI: 10.1093/infdis/jit639

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

Authors:  M Pittman
Journal:  Rev Infect Dis       Date:  1979 May-Jun

2.  Airborne transmission of Bordetella pertussis.

Authors:  Jason M Warfel; Joel Beren; Tod J Merkel
Journal:  J Infect Dis       Date:  2012-07-17       Impact factor: 5.226

Review 3.  Virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

4.  Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Authors:  Carey E Connelly; Yezhou Sun; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

5.  Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies).

Authors:  T Toyota; Y Kai; M Kakizaki; A Sakai; Y Goto; M Yajima; M Ui
Journal:  Tohoku J Exp Med       Date:  1980-02       Impact factor: 1.848

6.  Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.

Authors:  Carol S Inatsuka; Qian Xu; Ivan Vujkovic-Cvijin; Sandy Wong; Scott Stibitz; Jeff F Miller; Peggy A Cotter
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

7.  Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity.

Authors:  Carol S Inatsuka; Steven M Julio; Peggy A Cotter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

8.  Nonhuman primate model of pertussis.

Authors:  Jason M Warfel; Joel Beren; Vanessa K Kelly; Gloria Lee; Tod J Merkel
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

Review 9.  Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease.

Authors:  Nicholas H Carbonetti
Journal:  Curr Opin Pharmacol       Date:  2007-04-05       Impact factor: 5.547

10.  Pertussis: challenges today and for the future.

Authors:  James D Cherry
Journal:  PLoS Pathog       Date:  2013-07-25       Impact factor: 6.823

View more
  27 in total

Review 1.  Bordetella pertussis transmission.

Authors:  Elizabeth A Trainor; Tracy L Nicholson; Tod J Merkel
Journal:  Pathog Dis       Date:  2015-09-14       Impact factor: 3.166

Review 2.  Bordetella pertussis: new concepts in pathogenesis and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

3.  Modulation of Pertussis and Adenylate Cyclase Toxins by Sigma Factor RpoE in Bordetella pertussis.

Authors:  Mariette Barbier; Dylan T Boehm; Emel Sen-Kilic; Claire Bonnin; Theo Pinheiro; Casey Hoffman; Mary Gray; Erik Hewlett; F Heath Damron
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 4.  [Recent progress in clinical research on pertussis].

Authors:  Dan-Xia Wu; Qiang Chen; Kun-Ling Shen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

5.  Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin.

Authors:  Xianzhe Wang; James A Stapleton; Justin R Klesmith; Erik L Hewlett; Timothy A Whitehead; Jennifer A Maynard
Journal:  Biochemistry       Date:  2017-02-23       Impact factor: 3.162

Review 6.  Pertussis.

Authors:  Giovanni Gabutti; Chiara Azzari; Paolo Bonanni; Rosa Prato; Alberto E Tozzi; Alessandro Zanetti; Gianvincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 7.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 8.  Bordetella biofilms: a lifestyle leading to persistent infections.

Authors:  Natalia Cattelan; Purnima Dubey; Laura Arnal; Osvaldo M Yantorno; Rajendar Deora
Journal:  Pathog Dis       Date:  2015-11-19       Impact factor: 3.166

9.  Effect of maternal Tdap on infant antibody response to a primary vaccination series with whole cell pertussis vaccine in São Paulo, Brazil.

Authors:  Lourdes R A Vaz-de-Lima; Ana Paula S Sato; Lucia C Pawloski; Eder G Fernandes; Gowrisankar Rajam; Helena K Sato; Divya Patel; Han Li; Euclides A de Castilho; Maria Lucia Tondella; Jarad Schiffer
Journal:  Vaccine X       Date:  2021-02-16

10.  The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?

Authors:  Lawrence D Frenkel
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.